 BioCryst Pharmaceuticals Inc NASDAQ: BCRX shares are trading lower Monday morning after BofA Securities downgraded the stock and Oppenheimer lowered its price target. BofA Securities analyst Tazeen Ahmad downgraded BioCryst from a Buy rating to a Neutral rating and announced a. 